return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Board of Directors
Management Team
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Media Centre
Overview
Newsletters
Coverage
Investor Videos
NOX Insights
Noxopharm Podcasts
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
7-May-2020
Trading Halt
1-May-2020
Change in substantial holding
1-May-2020
Change in substantial holding
30-Apr-2020
Noxopharm March 2020 Quarterly Report & Appendix 4C
30-Apr-2020
Abscopal Responses Achieved in Prostate Cancer
23-Apr-2020
Pipeline Expands With Potential New Brain Cancer Treatment
21-Apr-2020
Approval to be sought for COVID-19 Clinical Study in U.S.
20-Apr-2020
Receipt of cash payment for collateral shares
7-Apr-2020
Noxopharm trial data to be presented at ASCO 2020
2-Apr-2020
Updated Noxopharm Virtual Roadshow Corporate Presentation
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
